Search

The compound 3,4‐diaminopyridine (3,4‐AP), a derivative of 4‐aminopyridine (4‐AP), is used in the symptomatic treatment of fatigue in multiple sclerosis as well as Lambert–Eaton myasthenia syndrome whereas the parent compound 4‐AP is used as an acetylcholine‐releasing drug, in serum, saliva, and urine. 4‐AP is an experimental drug that may reduce symptoms in some people with multiple sclerosis, particularly those who are more sensitive to heat. The carbon nanotubes (CNTs) have inside cavity tethering on the surface upon functionalization and adsorption on the walls of CNTs, which provides extra ability to carry pharmaceutical agents through multiple ways. Due to these benefits, this communication will discuss the comparative changes in geometry, electronic properties, and shielding parameters of 4‐AP and 3,4‐AP absorbed C56H16. The DFT/B3LYP/6–31G (d, p) method is used for the first time to report electronic structure and interaction parameters on the CNT surface. The same level theory is used to discuss the thermodynamic stability of CNT‐4‐AP/3,4‐AP. The calculated UV spectra of CNT are compared with UV spectra of CNT‐4‐AP and 3,4‐AP by using the same level theory in a water solvent, which provides a better comprehension of CNT as a drug delivery system after absorption of the 4‐AP and 3,4‐AP in the human body. The nature and strength of interactions have been discussed with the help of AIM analysis, and the frontier orbital highest occupied molecular orbital–lowest unoccupied molecular orbital (HOMO–LUMO) gap, chemical softness, and chemical hardness have been calculated to understand its complete chemical properties. The characters of the frontier molecular orbitals are discussed and analyzed by comparing the DOS spectra of CNT with CNT‐4‐AP/3,4‐AP. [ABSTRACT FROM AUTHOR]